# Fertility Preservation in Breast Cancer Patients

> **NCT02661932** · PHASE4 · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 65 (actual)

## Conditions studied

- Breast Neoplasms
- Fertility

## Interventions

- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT02661932
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2018-03
- **Final completion:** 2024-12
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661932, "Fertility Preservation in Breast Cancer Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02661932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*